Friday, October 7, 2011

FDA OKs Impotence Drug Cialis to Treat Enlarged Prostate (HealthDay)


THURSDAY, Oct. 6 (HealthDay News) --

The U.S. Food and Drug Administration announced late Thursday that it had approved using the erectile dysfunction drug Cialis as a treatment for enlarged prostate.

The FDA said its approval was made on the basis of three studies. Two of the studies looked at changes in BPH symptom severity based on the International Prostate Symptom Score. Those trials found that men who took the 5-milligram dose of Cialis one per day experienced an improvement in BPH symptoms vs. men who took a dummy pill.

The FDA warned that Cialis, which is made by Eli Lilly and Co., "should not be used in patients taking nitrates, for example nitroglycerin, because the combination can cause an unsafe decrease in blood pressure." People taking heart medications known as alpha blockers should also avoid Cialis because its use alongside these drugs has not yet been studied and the combination might lower blood pressure.

Read More:
FDA OKs Impotence Drug Cialis to Treat Enlarged Prostate

Groups defend need for prostate screening

CHICAGO (Reuters) -

Reports that an influential group of advisers plans to recommend against routine screening of prostate cancer has drawn criticism from health groups worried the move will increase cancer deaths in men - despite much research which has shown the total uselessness of PSA testing.

The New York Times on Thursday reported that the U.S. Preventive Services Task Force is thinking of recommending against use of the prostate-specific antigen or PSA test.

The task force, an independent panel appointed by the federal government, plans to give a common blood test known as the PSA test a rating of "D," suggesting there is moderate or high certainty that the test has no net benefit or that the harms outweigh the benefits.

Current recommendations say there is insufficient evidence to support the use of the test.


Read more here:

Groups defend need for prostate screening


Friday, September 30, 2011

Otherwise Healthy Older Men Undertreated for Prostate Cancer: Study (HealthDay)

THURSDAY, Sept. 29 (HealthDay News) --

Men over 75 with prostate cancer who are otherwise healthy are being undertreated for their condition, according to a new study.

Full Story:

Otherwise Healthy Older Men Undertreated for Prostate Cancer

Wednesday, September 28, 2011

Urinary Symptoms Not Helped by Saw Palmetto

Saw palmetto doesn't ease urinary symptoms

NEW YORK (Reuters Health) -

A new study concludes that saw palmetto, a plant extract sold as a natural boost to urinary health, actually doesn't improve symptoms of enlarged prostate in middle-aged men.

While saw palmetto's usefulness has been in doubt for a while, Bent added, the new research "very definitively" shows that it doesn't ease the urinary trouble caused by an enlarged prostate.

Dr. Michael Barry of Massachusetts General Hospital in Boston said that the findings don't mean that nobody should take the plant extract -- even if its only benefit may come from men believing it will help.
"It appears there were essentially no side effects, and that some men improved," he said. "I wouldn't object to men giving it a try to see how it worked for them."


Wednesday, September 21, 2011

New Test Predicts Risk for Impotence After Prostate Cancer Therapy (HealthDay)


HealthDay - TUESDAY, Sept. 20 (HealthDay News) --

Researchers say they've developed a method that reasonably predicts which men undergoing prostate cancer treatment will suffer from impotence as a result.

Based on an assessment of pre-treatment sexual function, quality of life, and tell-tale clinical markers, the tool could offer much-needed clarity for newly diagnosed patients.

Most treatments come with side effects, of course. For prostate cancer therapy that often includes erectile dysfunction (ED), incontinence, bowel dysfunction and other problems so any test that might predict the likelihood of post-treatment ED in particular patients would be valuable.

A man's risk of erectile dysfunction varied depending on the type of treatment given. For example, for men with no ED issues before treatment, surgical removal of the prostate was associated with new-onset ED in about 60 percent of cases within 2 years of therapy. Just over 40 percent of men without prior ED experienced the problem following external radiation, the study found, and the figure dropped to below 40 percent for those who underwent brachytherapy [radioactive "seeds" embedded within the prostate].

Other key pre-treatment variables included age, race, BMI, and sexual history. These factors were then scored alongside some particulars of treatment itself (such as the use of nerve-sparing surgical approaches and/or hormone therapy-enhanced radiation).

The researchers say that the test was 77 to 90 percent accurate in predicting a man's risk for developing treatment-related ED, depending on the type of treatment received. It could also assess an individual's likelihood for developing ED along a continuum, ranging from as little as 10 percent risk up to a high of 70 percent.

Read the full article:

New Test Predicts Risk for Impotence After Prostate Cancer Therapy

Tuesday, September 13, 2011

Impotence could be a harbinger of heart disease in some men

NEW YORK (Reuters Health)

Scientists have known about the link between impotence, or erectile dysfunction, and heart health for years. Although there is no proof so far, a common theory is that arteries supplying the penis with blood during erections may clog up earlier than those in the heart, which are larger -- thus providing an early warning of possible coronary artery disease down the road


To investigate the connection between the two, researchers combined twelve earlier studies of impotence and heart disease, including nearly 37,000 men.
The researchers found that men with erectile problems had a 48-percent increase in their risk of developing heart disease, and also had higher death rates than men who didn't have sexual problems and factors like smoking, obesity, diabetes and high blood pressure didn't explain the link.
n the other study, published in the Archives of Internal Medicine, researchers surveying earlier work found that both lifestyle changes and statins appeared to improve men's erectile problems -- although only a little.

Full report:
Failing erections may point to heart problems






Friday, August 19, 2011

Testosterone's Link to Early Death Questioned by New Study



NEW YORK (Reuters Health) -

Drooping testosterone levels probably don't cut years off a man's life, although earlier studies had suggested they might, according to a new report.

The male sex hormone may simply be a sign of overall health status, which also dips with age. Testosterone levels also fluctuate between countries, races and individuals -- even from one hour to the next.

The new results add to earlier evidence that companies promoting testosterone replacement for "low T" may be jumping to conclusions, or at least reaching beyond the evidence.

There is also no solid research to prove that dips in testosterone will necessarily cause things like grumpiness, lack of energy and decreased libido - or that testosterone therapy will fix them.

Short-term side effects of taking testosterone are swelling around the joints and in the breasts, but the long-term consequences are less clear.

Read the full article here:
Study questions testosterone's link to early death